Daniel L. Flynn
Overview
Daniel L. Flynn received an average of $2M in total compensation, including $418K in salary, at Deciphera Pharmaceuticals from 2017 to 2021.
Source: SEC filings on April 26, 2022 and April 3, 2018.
Related executives
We found six more executives who work or worked at Deciphera Pharmaceuticals.
Steven Hoerter
Deciphera Pharmaceuticals
Chief Executive Officer
Matthew Sherman
Deciphera Pharmaceuticals
Chief Medical Officer
Thomas Kelly
Deciphera Pharmaceuticals
Chief Financial Officer
Daniel Martin
Deciphera Pharmaceuticals
Chief Commercial Officer
Michael Taylor
Deciphera Pharmaceuticals
Chief Executive Officer
Christopher Morl
Deciphera Pharmaceuticals